DYN
Dyne Therapeutics, Inc Earnings
$8.17
Earnings Summary
Revenue | $0Mn |
Net Profits | $-89.54Mn |
Net Profit Margins | -Inf% |
Dyne Therapeutics, Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2024. On a quarterly growth basis, Dyne Therapeutics, Inc has generated NaN% jump in its revenue since last 3-months.
Dyne Therapeutics, Inc’s net profit fell -34.37% since last year same period to $-89.54Mn in the Q4 2024. On a quarterly growth basis, Dyne Therapeutics, Inc has generated 7.81% jump in its net profits since last 3-months.
Dyne Therapeutics, Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2024. On a quarterly growth basis, Dyne Therapeutics, Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.91 |
EPS Estimate Current Year | -0.91 |
Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current quarter stand at -0.91 - a -28.45% fall from last quarter’s estimates.
Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current year stand at -0.91.
Key Ratios
Earning Per Share (EPS) | -0.88 |
Dyne Therapeutics, Inc’s earning per share (EPS) jumped 19.27% since last year same period to -0.88 in the Q4 2024. This indicates that the Dyne Therapeutics, Inc has generated 19.27% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-02 | -0.8 | -0.81 | -1.25% |
2025-02-27 | -0.91 | -0.88 | 3.51% |
2024-09-30 | -0.71 | -0.96 | -35.61% |
2024-08-12 | -0.72 | -0.7 | 2.78% |
